Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 3, 2007, Pages 480-486

  Corti, Giovanna ^a   Capasso, Gaetano ^a   Maestrelli, Francesca ^a   Cirri, Marzia ^a   Mura, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Differential scanning calorimetry; Dissolution rate; Fourier transform infrared spectroscopy; Metformin hydrochloride; Scanning electron microscopy; Triacetyl cyclodextrin; X ray powder diffractometry

Indexed keywords

BETA CYCLODEXTRIN; METFORMIN;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SPRAY DRYING;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HYPOGLYCEMIC AGENTS; METFORMIN; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; X-RAY DIFFRACTION;

EID: 35348871191     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.07.018     Document Type: Article

References (21)

1. Hirayama F., and Uekama K. Adv. Drug Delivery Rev. 36 (1999) 125-141
2. Uekama K., Hirayama F., and Irie T. Chem. Rev. 98 (1998) 2045-2076
3. Loftsson T., and Duchêne D. Int. J. Pharm. 329 (2007) 1-11
4. Loftsson T., Hreinsdóttir D., and Másson M. Int. J. Pharm. 302 (2005) 18-28
5. Mura P., Furlanetto S., Cirri M., Maestrelli F., Corti G., and Pinzauti S. J. Pharm. Biomed. Anal. 37 (2005) 987-994
6. Pinto L.M.A., Fernandes Fraceto L., Santana M.H.A., Pertinhez T.A., Oyama Jr. S., and de Paula E. J. Pharm. Biomed. Anal. 39 (2005) 956-963
7. Liu L., and Zhu S. J. Pharm. Biomed. Anal. 40 (2006) 122-127
8. Nakanishi K., Masukawa T., Nadai T., Yoshii K., Okada S., and Miyajima K. Biol. Pharm. Bull. 20 (1997) 66-70
9. Fernandes C.M., and Veiga F.J.B. Chem. Pharm. Bull. 50 (2002) 1597-1602
10. Marques Fernandes C., Ramos P., Celta Falcão A., and Veiga F.J.B. J. Control. Release 88 (2003) 127-134
11. Marchetti P., and Navalesi R. Clin. Pharmacokinet. 16 (1989) 100-128
12. Scheen A.J. Clin. Pharmacokinet. 30 (1996) 359-371
13. Vidon N., Chaussade S., Noel M., Franchisseur C., Huchet B., and Bernier J.J. Diab. Res. Clin. Pract. 4 (1988) 223-229
14. Marathe P.H., Wen Y., Norton J., Greene D.S., Barbhaiya T.F., and Wilding I.R. Br. J. Clin. Pharmacol. 50 (2000) 325-332
15. Mura P., Adragna E., Rabasco A.M., Moyano J.R., Pérez-Martìnez J.I., Arias M.J., and Ginés J.M. Drug Dev. Ind. Pharm. 25 (1999) 279-287
16. Mura P., Faucci M.T., Parrini P.L., Furlanetto S., and Pinzauti S. Int. J. Pharm. 179 (1999) 117-128
17. Junco S., Casimiro T., Ribeiro M., Nunes Da Ponte M., and Cabral Marques H. J. Incl. Phenom. 44 (2002) 117-121
18. Bettinetti G.P., Sorrenti M., Rossi S., Ferrari F., Mura P., and Faucci M.T. J. Pharm. Biomed. Anal. 30 (2002) 1173-1179
19. Bettinetti G.P., Mura P., Faucci M.T., Sorrenti M., and Setti M. Eur. J. Pharm. Sci. 15 (2002) 21-29
20. Khan K.A. J. Pharm. Pharmacol. 27 (1975) 48-49
21. Bettinetti G.P., Sorrenti M., Catenacci L., Ferrari F., and Rossi S. J. Pharm. Biomed. Anal. 41 (2006) 1121-1205